BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

259 related articles for article (PubMed ID: 36791750)

  • 1. Uterine Neoplasms, Version 1.2023, NCCN Clinical Practice Guidelines in Oncology.
    Abu-Rustum N; Yashar C; Arend R; Barber E; Bradley K; Brooks R; Campos SM; Chino J; Chon HS; Chu C; Crispens MA; Damast S; Fisher CM; Frederick P; Gaffney DK; Giuntoli R; Han E; Holmes J; Howitt BE; Lea J; Mariani A; Mutch D; Nagel C; Nekhlyudov L; Podoll M; Salani R; Schorge J; Siedel J; Sisodia R; Soliman P; Ueda S; Urban R; Wethington SL; Wyse E; Zanotti K; McMillian NR; Aggarwal S
    J Natl Compr Canc Netw; 2023 Feb; 21(2):181-209. PubMed ID: 36791750
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Uterine neoplasms, version 1.2014.
    Koh WJ; Greer BE; Abu-Rustum NR; Apte SM; Campos SM; Chan J; Cho KR; Cohn D; Crispens MA; Dupont N; Eifel PJ; Fader AN; Fisher CM; Gaffney DK; George S; Han E; Huh WK; Lurain JR; Martin L; Mutch D; Remmenga SW; Reynolds RK; Small W; Teng N; Tillmanns T; Valea FA; McMillian N; Hughes M
    J Natl Compr Canc Netw; 2014 Feb; 12(2):248-80. PubMed ID: 24586086
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Issues in the Differential Diagnosis of Uterine Low-grade Endometrioid Carcinoma, Including Mixed Endometrial Carcinomas: Recommendations from the International Society of Gynecological Pathologists.
    Rabban JT; Gilks CB; Malpica A; Matias-Guiu X; Mittal K; Mutter GL; Oliva E; Parkash V; Ronnett BM; Staats P; Stewart CJR; McCluggage WG
    Int J Gynecol Pathol; 2019 Jan; 38 Suppl 1(Iss 1 Suppl 1):S25-S39. PubMed ID: 30550482
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Endometrial carcinomas: a review emphasizing overlapping and distinctive morphological and immunohistochemical features.
    Bartosch C; Manuel Lopes J; Oliva E
    Adv Anat Pathol; 2011 Nov; 18(6):415-37. PubMed ID: 21993268
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Mixed Endometrioid Adenocarcinoma and Müllerian Adenosarcoma of the Uterus and Ovary: Clinicopathologic Characterization With Emphasis on its Distinction From Carcinosarcoma.
    El Hallani S; Arora R; Lin DI; Måsbäc A; Mateoiu C; McCluggage WG; Nucci MR; Otis CN; Parkash V; Parra-Herran C; Longacre TA
    Am J Surg Pathol; 2021 Mar; 45(3):374-383. PubMed ID: 33565764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Uterine Carcinosarcomas - Diagnosis and Management.
    Denschlag D; Ulrich UA
    Oncol Res Treat; 2018; 41(11):675-679. PubMed ID: 30317231
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Uterine carcinosarcoma and high-risk endometrial carcinomas: a clinicopathological comparison.
    Zhang C; Hu W; Jia N; Li Q; Hua K; Tao X; Wang L; Feng W
    Int J Gynecol Cancer; 2015 May; 25(4):629-36. PubMed ID: 25633654
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Are the uterine serous carcinomas underdiagnosed? Histomorphologic and immunohistochemical correlates and clinical follow up in high-grade endometrial carcinomas initially diagnosed as high-grade endometrioid carcinoma.
    Hu S; Hinson JL; Matnani R; Cibull ML; Karabakhtsian RG
    Mod Pathol; 2018 Feb; 31(2):358-364. PubMed ID: 28984301
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Uterine malignant mixed mullerian tumors should not be included in studies of endometrial carcinoma.
    Vaidya AP; Horowitz NS; Oliva E; Halpern EF; Duska LR
    Gynecol Oncol; 2006 Nov; 103(2):684-7. PubMed ID: 16797683
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Uterine Neoplasms, Version 1.2018, NCCN Clinical Practice Guidelines in Oncology.
    Koh WJ; Abu-Rustum NR; Bean S; Bradley K; Campos SM; Cho KR; Chon HS; Chu C; Cohn D; Crispens MA; Damast S; Dorigo O; Eifel PJ; Fisher CM; Frederick P; Gaffney DK; George S; Han E; Higgins S; Huh WK; Lurain JR; Mariani A; Mutch D; Nagel C; Nekhlyudov L; Fader AN; Remmenga SW; Reynolds RK; Tillmanns T; Ueda S; Wyse E; Yashar CM; McMillian NR; Scavone JL
    J Natl Compr Canc Netw; 2018 Feb; 16(2):170-199. PubMed ID: 29439178
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Endometrial carcinosarcomas have a different prognosis and pattern of spread compared to high-risk epithelial endometrial cancer.
    Amant F; Cadron I; Fuso L; Berteloot P; de Jonge E; Jacomen G; Van Robaeys J; Neven P; Moerman P; Vergote I
    Gynecol Oncol; 2005 Aug; 98(2):274-80. PubMed ID: 15972232
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Comparative Survival Outcomes of Uterine Papillary Serous Carcinoma, Clear Cell Carcinoma, Grade 3 Endometrioid Adenocarcinoma, and Carcinosarcoma of Endometrial Cancer in Rajavithi Hospital.
    Prueksaritanond N; Chantape W
    J Med Assoc Thai; 2016 Feb; 99 Suppl 2():S75-83. PubMed ID: 27266220
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Endometrioid carcinomas of the uterine corpus with sex cord-like formations, hyalinization, and other unusual morphologic features: a report of 31 cases of a neoplasm that may be confused with carcinosarcoma and other uterine neoplasms.
    Murray SK; Clement PB; Young RH
    Am J Surg Pathol; 2005 Feb; 29(2):157-66. PubMed ID: 15644772
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Role of epithelial-mesenchymal transition factors in the histogenesis of uterine carcinomas.
    Franceschi T; Durieux E; Morel AP; de Saint Hilaire P; Ray-Coquard I; Puisieux A; Devouassoux-Shisheboran M
    Virchows Arch; 2019 Jul; 475(1):85-94. PubMed ID: 30739164
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Correlation between preoperative endometrial sampling and final endometrial cancer histology.
    Sany O; Singh K; Jha S
    Eur J Gynaecol Oncol; 2012; 33(2):142-4. PubMed ID: 22611951
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [New features in the 2014 WHO classification of uterine neoplasms].
    Lax SF
    Pathologe; 2016 Nov; 37(6):500-511. PubMed ID: 27738815
    [TBL] [Abstract][Full Text] [Related]  

  • 17. NCCN Guidelines® Insights: Uterine Neoplasms, Version 3.2021.
    Abu-Rustum NR; Yashar CM; Bradley K; Campos SM; Chino J; Chon HS; Chu C; Cohn D; Crispens MA; Damast S; Diver E; Fisher CM; Frederick P; Gaffney DK; George S; Giuntoli R; Han E; Howitt B; Huh WK; Lea J; Mariani A; Mutch D; Nekhlyudov L; Podoll M; Remmenga SW; Reynolds RK; Salani R; Sisodia R; Soliman P; Tanner E; Ueda S; Urban R; Wethington SL; Wyse E; Zanotti K; McMillian NR; Motter AD
    J Natl Compr Canc Netw; 2021 Aug; 19(8):888-895. PubMed ID: 34416706
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Malignant peritoneal cytology and increased mortality risk in stage I non-endometrioid endometrial cancer.
    Matsuo K; Nusbaum DJ; Matsuzaki S; Chang EJ; Roman LD; Wright JD; Harter P; Klar M
    Gynecol Oncol; 2020 Oct; 159(1):43-51. PubMed ID: 32690393
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prognoses and prognostic factors of carcinosarcoma, endometrial stromal sarcoma and uterine leiomyosarcoma: a comparison with uterine endometrial adenocarcinoma.
    Akahira J; Tokunaga H; Toyoshima M; Takano T; Nagase S; Yoshinaga K; Tase T; Wada Y; Ito K; Niikura H; Yamada H; Sato A; Sasano H; Yaegashi N
    Oncology; 2006; 71(5-6):333-40. PubMed ID: 17690557
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Incidence and effects on mortality of venous thromboembolism in elderly women with endometrial cancer.
    Rauh-Hain JA; Hariton E; Clemmer J; Clark RM; Hall T; Boruta DM; Schorge JO; Del Carmen MG
    Obstet Gynecol; 2015 Jun; 125(6):1362-1370. PubMed ID: 26000507
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.